Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Hepatic Steatosis on Prognosis and Outcomes of Patients With Chronic Hepatitis B

NCT02392598 is registered in ClinicalTrials.gov with Fatty Liver and Alcoholic Liver Disease Study Group, China as lead sponsor.

NCT NCT02392598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Hepatic Steatosis on Prognosis and Outcomes of Patients With Chronic Hepatitis B
Lead sponsor
Fatty Liver and Alcoholic Liver Disease Study Group, China
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2015
Completion date
December 31, 2020
Enrollment
3,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic steatosis, hepatitis b, chronic